Suppr超能文献

血浆激肽释放酶肝脏清除的识别位点位于其重链上,在激肽原酶上呈潜伏状态。

The recognition site for hepatic clearance of plasma kallikrein is on its heavy chain and is latent on prokallikrein.

作者信息

Borges D R, Kouyoumdjian M

机构信息

Department of Medicine (Gastroenterology Division), Escola Paulista de Medicina, São Paulo, Brazil.

出版信息

J Hepatol. 1992 Sep;16(1-2):115-21. doi: 10.1016/s0168-8278(05)80103-5.

Abstract

We partially purified the glycoproteins prokallikrein and kallikrein from rat plasma. The purification of rat plasma kallikrein may result in two forms: an intact form (alpha, M(r) 84-87 kDa) and a partially degraded form (beta, M(r) 46-51 kDa). The alpha-form is composed of a heavy chain (M(r) 50 kDa) and a light chain (M(r) 34-37 kDa) linked by a disulfide bond. The catalytic site is found on the light chain. The beta-form has a partially degraded heavy chain (M(r) 28 kDa). Using a preparation of exsanguinated and perfused rat liver, we verified that rat plasma prokallikrein is not activated by the liver and that neither the proenzyme nor the light chain is removed by the organ. Both forms (alpha and beta) of the active enzyme are similarly removed from the perfusate. We also observed that the clearance of plasma kallikrein is temperature-dependent, and not affected by substances that inhibit binding to galactosyl-, mannosyl-, fucosyl- or phosphomannosyl-specific lectins, but inhibited by beta-galactosides. We suggest that: (a) the binding site to hepatocytes is latent on prokallikrein and is located on its heavy chain, more specifically on the 28-kDa fragment still present in the beta form of the active enzyme and (b) plasma kallikrein is recognized by an S-type lectin.

摘要

我们从大鼠血浆中部分纯化了糖蛋白前激肽释放酶和激肽释放酶。大鼠血浆激肽释放酶的纯化可能产生两种形式:完整形式(α,相对分子质量84 - 87 kDa)和部分降解形式(β,相对分子质量46 - 51 kDa)。α形式由一条重链(相对分子质量50 kDa)和一条轻链(相对分子质量34 - 37 kDa)通过二硫键连接而成。催化位点位于轻链上。β形式有一条部分降解的重链(相对分子质量28 kDa)。使用放血并灌注的大鼠肝脏制剂,我们证实大鼠血浆前激肽释放酶不会被肝脏激活,并且该酶原和轻链均不会被该器官清除。活性酶的两种形式(α和β)从灌注液中被清除的情况相似。我们还观察到血浆激肽释放酶的清除是温度依赖性的,不受抑制与半乳糖基、甘露糖基、岩藻糖基或磷酸甘露糖基特异性凝集素结合的物质影响,但受β - 半乳糖苷抑制。我们认为:(a)与肝细胞的结合位点在前激肽释放酶上是潜在的,位于其重链上,更具体地说是位于活性酶β形式中仍然存在的28 kDa片段上;(b)血浆激肽释放酶被一种S型凝集素识别。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验